Vertex Pharmaceuticals Stock Is Tumbling After Earnings. Here’s Why.
In This Article:
Vertex Pharmaceuticals stock was falling sharply Tuesday after the biotech company reported first-quarter earnings that missed analysts’ expectations and disclosed narrower-than-expected access to its new non-opioid painkiller. Shares were down 13%, putting the stock on track for its worst day since October 2020, according to Dow Jones Market Data. Reception to the earnings was mixed among analysts.
Terms and Privacy Policy